MAFB Gene Multicentric Carpotarsal Osteolysis Syndrome Genetic Test
At DNA Labs UAE, we offer the MAFB Gene Multicentric Carpotarsal Osteolysis Syndrome Genetic Test for individuals suspected of having this rare genetic disorder. This test can provide valuable information for diagnosis, prognosis, and management of the condition.
Test Details
The MAFB gene is associated with a rare genetic disorder called multicentric carpotarsal osteolysis syndrome (MCTO). MCTO is characterized by the progressive destruction and loss of bone in the hands and feet, leading to deformities and functional impairment.
Our MAFB Gene Multicentric Carpotarsal Osteolysis Syndrome Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes or even the entire genome. This enables us to identify mutations or variants in the MAFB gene that may be responsible for the development of the disorder.
By performing this genetic test, healthcare professionals can determine if there are any mutations or variants in the MAFB gene associated with MCTO. This information is crucial for accurate diagnosis, prognosis, and management of the condition.
In addition to diagnosis, our MAFB Gene Multicentric Carpotarsal Osteolysis Syndrome Genetic Test can also be used for carrier testing and prenatal diagnosis in families with a known MAFB gene mutation. This allows individuals and families to make informed decisions about their reproductive health.
Test Components and Price
The MAFB Gene Multicentric Carpotarsal Osteolysis Syndrome Genetic Test is priced at 4400.0 AED.
Components:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the MAFB Gene Multicentric Carpotarsal Osteolysis Syndrome Genetic Test, it is important to provide the clinical history of the patient. This includes any relevant information about the patient’s symptoms and medical background.
Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with MAFB Gene Multicentric Carpotarsal Osteolysis Syndrome NGS Genetic DNA Test gene MAFB. This helps in assessing the inheritance pattern and identifying potential carriers within the family.
It is crucial to seek guidance from a healthcare professional or genetic counselor throughout the testing process. They can interpret the results, provide appropriate counseling and support, and assist in making informed decisions about further medical management.
At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. Contact us today to learn more about the MAFB Gene Multicentric Carpotarsal Osteolysis Syndrome Genetic Test and how it can benefit you and your family.
Test Name | MAFB Gene Multicentric carpotarsal osteolysis syndrome Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MAFB Gene Multicentric carpotarsal osteolysis syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAFB Gene Multicentric carpotarsal osteolysis syndrome NGS Genetic DNA Test gene MAFB |
Test Details |
The MAFB gene is associated with a rare genetic disorder called multicentric carpotarsal osteolysis syndrome (MCTO). MCTO is characterized by the progressive destruction and loss of bone in the hands and feet, leading to deformities and functional impairment. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of MCTO, NGS can be used to identify mutations or variants in the MAFB gene that may be responsible for the development of the disorder. By performing an NGS genetic test on an individual suspected of having MCTO, healthcare professionals can determine if there are any mutations or variants in the MAFB gene that are associated with the disorder. This information can help with the diagnosis, prognosis, and management of the condition. Additionally, genetic testing can also be used for carrier testing and prenatal diagnosis in families with a known MAFB gene mutation. It’s important to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor, who can help interpret the results and provide appropriate counseling and support. |